BATS BZX Real-Time Price
As of 1:24pm ET
| 0.00 / 0.00%|
The 7 analysts offering 12-month price forecasts for NxStage Medical Inc have a median target of 28.00, with a high estimate of 30.00 and a low estimate of 25.00. The median estimate represents a +16.96% increase from the last price of 23.94.
The current consensus among 9 polled investment analysts is to Buy stock in NxStage Medical Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.